US Cycling hands Landis case to USADA
By Julien Pretot
PARIS (Reuters) – The U.S. Cycling Federation has referred
Floyd Landis’s doping case to the United States Anti-Doping
Agency (USADA), the organization said.
The federation said in a statement released late on
Saturday it had formally referred the case to the USADA, which
is “responsible for the adjudication of anti-doping cases
involving American athletes in the Olympic movement.”
It added it would make no further comment on Landis’s
positive test for the male sex hormone testosterone.
“To maintain the same level of sensitivity and respect for
both the rights of all athletes and due process as the Landis
case enters the formal disciplinary phase, we will continue to
refrain from comment until USADA reaches a final determination
and all appeals are exhausted,” it said.
“As the governing body responsible for the sport of cycling
in the United States and American athletes racing abroad, USA
Cycling will continue to maintain a zero-tolerance policy for
doping in our sport,” said Steve Johnson, chief executive
officer of the cycling federation.
The B sample results, Landis’s response and any documents
provided by the USADA will go to a review panel, which will
make a recommendation whether or not there is a case.
The USADA, based on that recommendation, will then decide
whether to charge Landis.
If the USADA does charge the rider, he will have the
opportunity to contest that decision and the recommended
sanction before a U.S panel of judges.
Landis’s lawyers could then take the matter to the Court of
Arbitration for Sport (CAS).
Landis tested positive for testosterone after an astounding
comeback in the final mountain stage of the Tour de France. It
came a day after a poor performance all-but knocked him out of
Both Landis’s A and B samples tested positive and the rider
faces a two-year ban from the sport.